Skip to main content
logo
Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
1.600
0.00 (0.00%)
Jan 28, 2026, 4:00 PM EST

Silence Therapeutics Revenue

Silence Therapeutics had revenue of $159.00K in the quarter ending September 30, 2025, a decrease of -89.39%. This brings the company's revenue in the last twelve months to $25.83M, up 18.13% year-over-year. In the year 2024, Silence Therapeutics had annual revenue of $41.20M with 27.54% growth.

Revenue (ttm)
25.83M
Revenue Growth
+18.13%
P/S Ratio
9.16
Revenue / Employee
222.67K
Employees
116
Market Cap
236.64M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202441.20M8.90M27.54%
Dec 31, 202332.30M10.65M49.17%
Dec 31, 202221.66M4.87M29.01%
Dec 31, 202116.78M9.29M124.07%
Dec 31, 20207.49M7.17M2,215.11%
Dec 31, 2019323.57K--
Dec 31, 2018---
Dec 31, 201721.62K-928.69K-97.72%
Dec 31, 2016950.31K--
Dec 31, 2015---
Dec 31, 201423.37K-170.40K-87.94%
Dec 31, 2013193.77K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BioStem Technologies292.21M
Vaxart148.20M
Nuo Therapeutics2.61M
Northwest Biotherapeutics937.00K
Arch Biopartners-62.11K
Revenue Rankings

Silence Therapeutics News

More News